Kou L - Search Results

1

Chondrocyte-targeted bilirubin/rapamycin carrier-free nanoparticles alleviate oxidative stress and modulate autophagy for osteoarthritis therapy.

Huang H, Liang X, Li S, Yan Y, Li S, Qiu C, Ye Z, Zhu Y, Shen D, Lin Y, Wang L, Chen N, Yao Y, Zhao X, Wu F, Shi X, Kou L, Chen R, Yao Q. Huang H, et al. Among authors: kou l. J Control Release. 2024 Dec 24;378:517-533. doi: 10.1016/j.jconrel.2024.12.024. Online ahead of print. J Control Release. 2024. PMID: 39701459

2

Therapeutic application and construction of bilirubin incorporated nanoparticles.

Yao Q, Chen R, Ganapathy V, Kou L. Yao Q, et al. Among authors: kou l. J Control Release. 2020 Dec 10;328:407-424. doi: 10.1016/j.jconrel.2020.08.054. Epub 2020 Sep 1. J Control Release. 2020. PMID: 32882272 Review.

3

Opsonized nanoparticles target and regulate macrophage polarization for osteoarthritis therapy: A trapping strategy.

Kou L, Huang H, Tang Y, Sun M, Li Y, Wu J, Zheng S, Zhao X, Chen D, Luo Z, Zhang X, Yao Q, Chen R. Kou L, et al. J Control Release. 2022 Jul;347:237-255. doi: 10.1016/j.jconrel.2022.04.037. Epub 2022 May 12. J Control Release. 2022. PMID: 35489544

4

Therapeutic options and drug delivery strategies for the prevention of intrauterine adhesions.

Kou L, Jiang X, Xiao S, Zhao YZ, Yao Q, Chen R. Kou L, et al. J Control Release. 2020 Feb;318:25-37. doi: 10.1016/j.jconrel.2019.12.007. Epub 2019 Dec 9. J Control Release. 2020. PMID: 31830539 Review.

5

Protective effects and mechanisms of bilirubin nanomedicine against acute pancreatitis.

Yao Q, Jiang X, Zhai YY, Luo LZ, Xu HL, Xiao J, Kou L, Zhao YZ. Yao Q, et al. Among authors: kou l. J Control Release. 2020 Jun 10;322:312-325. doi: 10.1016/j.jconrel.2020.03.034. Epub 2020 Apr 1. J Control Release. 2020. PMID: 32243974

6

Hyaluronic acid coated bilirubin nanoparticles attenuate ischemia reperfusion-induced acute kidney injury.

Huang ZW, Shi Y, Zhai YY, Du CC, Zhai J, Yu RJ, Kou L, Xiao J, Zhao YZ, Yao Q. Huang ZW, et al. Among authors: kou l. J Control Release. 2021 Jun 10;334:275-289. doi: 10.1016/j.jconrel.2021.04.033. Epub 2021 Apr 27. J Control Release. 2021. PMID: 33930479

7

Intra-articular drug delivery systems for osteoarthritis therapy: shifting from sustained release to enhancing penetration into cartilage.

Huang H, Lou Z, Zheng S, Wu J, Yao Q, Chen R, Kou L, Chen D. Huang H, et al. Among authors: kou l. Drug Deliv. 2022 Dec;29(1):767-791. doi: 10.1080/10717544.2022.2048130. Drug Deliv. 2022. PMID: 35261301 Free PMC article. Review.

8

Recombinant protein drugs-based intra articular drug delivery systems for osteoarthritis therapy.

Huang H, Lin Y, Jiang Y, Yao Q, Chen R, Zhao YZ, Kou L. Huang H, et al. Among authors: kou l. Eur J Pharm Biopharm. 2023 Feb;183:33-46. doi: 10.1016/j.ejpb.2022.12.012. Epub 2022 Dec 20. Eur J Pharm Biopharm. 2023. PMID: 36563886 Review.

9

Ultraviolet B radiation-induced JPH203-loaded keratinocyte extracellular vesicles exert etiological interventions for psoriasis therapy.

Jiang X, Jiang Z, Huang S, Mao P, Zhang L, Wang M, Ye J, Sun L, Sun M, Lu R, Sun T, Sheng H, Zhao X, Cai A, Ma X, Yao Q, Lin G, Chen R, Kou L. Jiang X, et al. Among authors: kou l. J Control Release. 2023 Oct;362:468-478. doi: 10.1016/j.jconrel.2023.08.059. Epub 2023 Sep 8. J Control Release. 2023. PMID: 37666304

10

Bilirubin ameliorates osteoarthritis via activating Nrf2/HO-1 pathway and suppressing NF-κB signalling.

Zhao X, Duan B, Wu J, Huang L, Dai S, Ding J, Sun M, Lin X, Jiang Y, Sun T, Lu R, Huang H, Lin G, Chen R, Yao Q, Kou L. Zhao X, et al. Among authors: kou l. J Cell Mol Med. 2024 Apr;28(7):e18173. doi: 10.1111/jcmm.18173. J Cell Mol Med. 2024. PMID: 38494841 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

548 results

Search Page

Filters